Production Of GSK's Ziagen HIV Oral Liquid Medicine

Paul Lucas, president and chief executive officer of GlaxoSmithKline Canada Inc., poses for a photograph in front of the production line at the company's Canadian headquarters in Mississauga, Ontario, Canada, on Monday, Dec. 13, 2010. Lucas has been head of GlaxoSmithKline's Canadian operations since 2000. Photographer: Norm Betts/Bloomberg via Getty Images
Paul Lucas, president and chief executive officer of GlaxoSmithKline Canada Inc., poses for a photograph in front of the production line at the company's Canadian headquarters in Mississauga, Ontario, Canada, on Monday, Dec. 13, 2010. Lucas has been head of GlaxoSmithKline's Canadian operations since 2000. Photographer: Norm Betts/Bloomberg via Getty Images
Production Of GSK's Ziagen HIV Oral Liquid Medicine
ACQUISTA UNA LICENZA
Come posso utilizzare questa immagine?
475,00 €
EUR

DETTAGLI

Restrizioni:
Contatta l'ufficio locale per informazioni su qualsiasi tipo di uso commerciale o promozionale.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Attestazione:
Bloomberg / Collaboratore
N. Editorial:
107630267
Collezione:
Bloomberg
Data di creazione:
13 dicembre 2010
Data di upload:
Tipo di licenza:
Info sulla liberatoria:
Senza liberatoria. Ulteriori informazioni
Fonte:
Bloomberg
Nome oggetto:
GLAXO